Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Hepatitis B Tests Market size was valued at USD 1.41 billion in 2024 and is expected to reach USD 2.93 billion by 2037, registering around 5.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of hepatitis B tests is assessed at USD 1.48 billion.
The growth of the market can be attributed to the growing prevalence of hepatitis B, and increasing awareness levels among patients associated with early detection of the disease. According to the World Health Organization, in 2019, 296 million in the world were living with chronic hepatitis B infection, with 1.5 million new infections every year. That same year, hepatitis B resulted in the deaths of 820,000 people globally. Along with these, rise in technological advancements in molecular diagnostics, and upsurge in blood transfusion and donations in patients with hepatitis are also expected to drive market growth significantly in the forthcoming years. Furthermore, rapidly growing biotechnology and biopharmaceutical industries around the world is projected to offer profitable opportunities to the market in the near future.
